1. Home
  2. PDCO vs MIRM Comparison

PDCO vs MIRM Comparison

Compare PDCO & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDCO
  • MIRM
  • Stock Information
  • Founded
  • PDCO 1877
  • MIRM 2018
  • Country
  • PDCO United States
  • MIRM United States
  • Employees
  • PDCO N/A
  • MIRM N/A
  • Industry
  • PDCO Medical Specialities
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDCO Health Care
  • MIRM Health Care
  • Exchange
  • PDCO Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • PDCO 1.9B
  • MIRM 1.9B
  • IPO Year
  • PDCO 1992
  • MIRM 2019
  • Fundamental
  • Price
  • PDCO $20.76
  • MIRM $42.21
  • Analyst Decision
  • PDCO Hold
  • MIRM Strong Buy
  • Analyst Count
  • PDCO 8
  • MIRM 13
  • Target Price
  • PDCO $27.25
  • MIRM $56.23
  • AVG Volume (30 Days)
  • PDCO 802.5K
  • MIRM 299.8K
  • Earning Date
  • PDCO 11-27-2024
  • MIRM 11-12-2024
  • Dividend Yield
  • PDCO 4.92%
  • MIRM N/A
  • EPS Growth
  • PDCO N/A
  • MIRM N/A
  • EPS
  • PDCO 1.83
  • MIRM N/A
  • Revenue
  • PDCO $6,533,269,000.00
  • MIRM $307,028,000.00
  • Revenue This Year
  • PDCO $2.74
  • MIRM $73.07
  • Revenue Next Year
  • PDCO $3.25
  • MIRM $27.98
  • P/E Ratio
  • PDCO $11.40
  • MIRM N/A
  • Revenue Growth
  • PDCO 0.13
  • MIRM 128.34
  • 52 Week Low
  • PDCO $19.89
  • MIRM $23.14
  • 52 Week High
  • PDCO $32.58
  • MIRM $45.81
  • Technical
  • Relative Strength Index (RSI)
  • PDCO 45.08
  • MIRM 63.51
  • Support Level
  • PDCO $20.62
  • MIRM $40.61
  • Resistance Level
  • PDCO $22.37
  • MIRM $42.58
  • Average True Range (ATR)
  • PDCO 0.59
  • MIRM 1.72
  • MACD
  • PDCO -0.00
  • MIRM 0.32
  • Stochastic Oscillator
  • PDCO 27.15
  • MIRM 52.96

About PDCO Patterson Companies Inc.

Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: